title: Death of a female cocaine user due to the serotonin syndrome following moclobemide-venlafaxine overdose.
abstract: To our knowledge, the majority of evidence supporting the relationship between the serotonin syndrome and medications that effect 5HT is based on case reports. The justification for taking up this subject has been a fatal outcome of a 21 year-old female following an administration of toxic doses of moclobemide (MAOI) and venlafaxine (SNRI). As a result of complex toxicological investigations including antemortem and postmortem material, antemortem clinical observations and postmortem examinations, the cause of death was identified as overdose with antidepressants--moclobemide and venlafaxine--in the mechanism of the clinically fully developed severe toxic serotonin syndrome. The analysis of a hair strand collected from the victim documented the use of the above-mentioned drugs simultaneously with cocaine in the period of at least 20 months preceding death. The fact is a matter of considerable interest in view of the employed pharmacotherapy, giving rise to suspicion that the woman had not developed the serotonin syndrome during the almost 2-year antemortem period until she took toxic doses of both medications.
authors.affiliation: Institute of Forensic Medicine Jagiellonian University Collegium Medicum, Toxicology Department, Grzegorzecka St. 16, 31-531 Krakow, Poland. mpklys@cyf-kr.edu.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Kłys
authors.forename: Piotr
authors.initials: P
authors.lastname: Kowalski
authors.forename: Sebastian
authors.initials: S
authors.lastname: Rojek
authors.forename: Adam
authors.initials: A
authors.lastname: Gross
mesh_terms: D003042:Cocaine / Q000032:analysis; D019970:Cocaine-Related Disorders / Q000150:complications*; D003511:Cyclohexanols / Q000032:analysis / Q000506:poisoning*; D018765:Dopamine Uptake Inhibitors / Q000032:analysis; D062787:Drug Overdose; D005260:Female; D053593:Forensic Toxicology; D006197:Hair / Q000737:chemistry; D006801:Humans; D020912:Moclobemide / Q000032:analysis / Q000506:poisoning*; D008996:Monoamine Oxidase Inhibitors / Q000032:analysis / Q000506:poisoning*; D020230:Serotonin Syndrome / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000032:analysis / Q000506:poisoning*; D000069470:Venlafaxine Hydrochloride; D055815:Young Adult
chemical_list: D003042:Cocaine; D003511:Cyclohexanols; D018765:Dopamine Uptake Inhibitors; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride